End Price Gouging for Medications Act

# End Price Gouging for Medications Act Summary **What the Bill Would Do:** This bill aims to prevent pharmaceutical companies from excessively raising drug prices. If passed, it would allow the federal government to take action against what it defines as "price gouging" on medications—essentially sudden, unjustified price increases. The legislation would give regulators tools to investigate and penalize drug manufacturers that raise prices beyond certain thresholds without valid reasons like increased production costs or inflation. **Who It Affects:** The bill would primarily impact pharmaceutical companies that manufacture prescription drugs, as well as patients and insurance companies that pay for medications.

Americans who rely on prescription drugs—particularly those on fixed incomes or without comprehensive insurance coverage—could benefit from potentially lower drug prices. **Current Status:** The bill is currently in committee (S 1753 in the Senate), meaning it has been introduced but has not yet advanced to a full vote. It was sponsored by Senator Jeff Merkley (D-OR). The bill has not yet become law and would need to pass committee review, a Senate vote, House approval, and presidential signature before taking effect.